Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation

Irene Cavattoni

Tatjana ZabelinaDepartment of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Francis AyukDepartment of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Christine WolschkeDepartment of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Ulrike BacherDepartment of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Axel ZanderDepartment of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Nicolaus KrögerDepartment of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, GermanyCorrespondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Acknowledgments

We thank the staff of the BMT unit for providing excellent care of our patients and the medical technicians for their excellent work in the laboratories.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation

Information for

Open access

Opportunities

Help and information

Pilot study of rituximab plus donor-lymphocyte infusion to prevent or treat relapse in B-cell lymphoma after allogeneic stem cell transplantation

Acknowledgments

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature